13F HOLDINGS REPORT
Bain Capital Life Sciences Investors, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0000950123-23-010856
Total Value
$894.2M
Positions
31
Other Managers
11
Confidential Omitted
No
Holdings (31)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NUVALENT INC | NUVL | 3,577,267 | $164.4M | 18.39% |
| 2 | PHARVARIS N V | PHVS | 4,784,674 | $99.9M | 11.17% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 10,473,913 | $96.9M | 10.83% |
| 4 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 3,081,307 | $71.2M | 7.97% |
| 5 | DISC MEDICINE INC | IRON | 1,332,545 | $62.6M | 7.00% |
| 6 | SAVARA INC | SVRA | 14,232,751 | $53.8M | 6.02% |
| 7 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,275,552 | $37.9M | 4.24% |
| 8 | TANGO THERAPEUTICS INC | TNGX | 2,892,663 | $32.6M | 3.64% |
| 9 | NATERA INC | NTRA | 700,197 | $31.0M | 3.46% |
| 10 | CABALETTA BIO INC | CABA | 2,000,000 | $30.4M | 3.40% |
| 11 | ACLARIS THERAPEUTICS INC | ACRS | 3,400,000 | $23.3M | 2.60% |
| 12 | EQRX INC | 26886C107 | 10,003,573 | $22.2M | 2.48% |
| 13 | X4 PHARMACEUTICALS INC | XFOR | 15,960,588 | $17.4M | 1.95% |
| 14 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 3,000,000 | $15.9M | 1.78% |
| 15 | NURIX THERAPEUTICS INC | NRIX | 1,822,883 | $14.3M | 1.60% |
| 16 | CYMABAY THERAPEUTICS INC | 23257D103 | 913,969 | $13.6M | 1.52% |
| 17 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 915,000 | $13.5M | 1.51% |
| 18 | ANNEXON INC | ANNX | 5,701,926 | $13.5M | 1.50% |
| 19 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 1,431,058 | $11.5M | 1.29% |
| 20 | MERSANA THERAPEUTICS INC | 59045L106 | 8,663,673 | $11.0M | 1.23% |
| 21 | RAPID MICRO BIOSYSTEMS INC | RPID | 8,434,560 | $9.1M | 1.02% |
| 22 | SYROS PHARMACEUTICALS INC | 87184Q206 | 2,124,694 | $8.4M | 0.94% |
| 23 | SOLID BIOSCIENCES INC | SLDB | 3,130,422 | $7.9M | 0.88% |
| 24 | ATEA PHARMACEUTICALS INC | AVIR | 2,485,638 | $7.5M | 0.83% |
| 25 | NAUTILUS BIOTECHNOLOGY INC | NAUT | 2,000,000 | $6.3M | 0.71% |
| 26 | XILIO THERAPEUTICS INC | XLO | 2,805,413 | $5.9M | 0.66% |
| 27 | 2SEVENTY BIO INC | 901384107 | 1,408,901 | $5.5M | 0.62% |
| 28 | INVIVYD INC | IVVD | 1,937,207 | $3.3M | 0.37% |
| 29 | C4 THERAPEUTICS INC | CCCC | 1,642,210 | $3.1M | 0.34% |
| 30 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $190,000 | 0.02% |
| 31 | CARA THERAPEUTICS INC | 140755109 | 23,646 | $39,725 | 0.00% |